Thalidomide-O-amido-C6-NH2 (TFA), 500mg

5-Aminobenzo[d]oxazol-2(3H)-one, 95.0%, 5g

cis-5-methyl-2,3,3a,4,7,7a-hexahydro-1H-isoindole, 95.0%, 250mg

N2-butyl-1,3,5-triazine-2,4,6-triamine, 98%, 100g

4-(Trifluoromethyl)cyclohexylamine (cis- and trans- mixture)>98.0%(GC)1g

2-(4-Ethoxyphenyl)ethanol, 95+%, 1g

4-Cyclohex-1-enyl-morpholine, 95.0%, 25g

2-Boc-6-Amino-2-aza-spiro[3.3]heptane, 95.0%, 25g

1,2,3,5,6-Pentathiepane, 95.0%, 5g

1H-Pyrrolo[3,2-h]quinoline-2-carboxylic acid, 95.0%, 1g

Ethyl 1-benzyl-4-oxopyrrolidine-3-carboxylate hydrochloride, 95.0%, 5g

Ethyl 2-(3-iodophenyl)acetate, 97%, 1g

Sodium 2'-(dicyclohexylphosphino)-2,6-diisopropylbiphenyl-4-sulfonate, 97%, 250mg